Details for Patent: 11,752,154
Which drugs does patent 11,752,154 protect, and when does it expire?
Patent 11,752,154 protects SEPHIENCE and is included in one NDA.
This patent has nine patent family members in seven countries.
Summary for Patent: 11,752,154
| Title: | Pharmaceutical compositions comprising sepiapterin and uses thereof |
| Abstract: | The present invention features pharmaceutical compositions including sepiapterin, or a pharmaceutically acceptable salt and/or co-crystal thereof, and methods for the treatment of tetrahydrobiopterin-related disorders (e.g., tetrahydrobiopterin deficiency or phenylketonuria) with such compositions. |
| Inventor(s): | Daniel E. Levy |
| Assignee: | PTC Therapeutics MP Inc |
| Application Number: | US16/670,362 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 11,752,154
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ptc Therap | SEPHIENCE | sepiapterin | POWDER;ORAL | 219666-002 | Jul 28, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | TREATMENT OF HYPERPHENYLALANINEMIA (HPA) IN ADULT AND PEDIATRIC PATIENTS WITH SEPIAPTERIN-RESPONSIVE PHENYLKETONURIA (PKU) BY ADMINISTERING SEPIAPTERIN | ⤷ Start Trial | |||
| Ptc Therap | SEPHIENCE | sepiapterin | POWDER;ORAL | 219666-001 | Jul 28, 2025 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | TREATMENT OF HYPERPHENYLALANINEMIA (HPA) IN ADULT AND PEDIATRIC PATIENTS WITH SEPIAPTERIN-RESPONSIVE PHENYLKETONURIA (PKU) BY ADMINISTERING SEPIAPTERIN | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,752,154
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Brazil | 112020003865 | ⤷ Start Trial | |||
| Canada | 3073957 | ⤷ Start Trial | |||
| China | 111491635 | ⤷ Start Trial | |||
| European Patent Office | 3675863 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
